NASDAQ: BRTX
Biorestorative Therapies Inc Stock Ownership - Who owns Biorestorative Therapies?

Insider buying vs selling

Have Biorestorative Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lance AlstodtPresident CEO COB2025-10-0615,625$1.60
$25.00kBuy
Francisco SilvaVP of Research and Development2025-10-0611,719$1.60
$18.75kBuy

1 of 1

BRTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRTX insiders and whales buy or sell their stock.

BRTX Shareholders

What type of owners hold Biorestorative Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Westbury Bermuda Ltd258.06%65,750,000$15.32MInsider
Trust Westbury74.77%19,049,578$4.44MInsider
Antonio Joel San49.06%12,500,000$2.91MInsider
Janet Montgomery7.28%1,854,428$432.08kInsider
Dale Broadrick7.04%1,793,808$417.96kInsider
John M. Desmarais1.94%493,398$114.96kInsider
Joseph B. Swiader0.75%191,267$44.57kInsider
Lance Alstodt0.74%187,497$43.69kInsider
Francisco Silva0.72%183,520$42.76kInsider
Paul Jude Tonna0.49%123,850$28.86kInsider

1 of 3

BRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRTX0.32%99.68%Net Buying
ACXP4.85%90.09%
TCRT0.39%99.61%Net BuyingNet Buying
CNSP9.85%90.15%
ENVB1.28%14.54%

Biorestorative Therapies Stock Ownership FAQ

Who owns Biorestorative Therapies?

Biorestorative Therapies (NASDAQ: BRTX) is owned by 1.28% institutional shareholders, 401.92% Biorestorative Therapies insiders, and 0.00% retail investors. Westbury Bermuda Ltd is the largest individual Biorestorative Therapies shareholder, owning 65.75M shares representing 258.06% of the company. Westbury Bermuda Ltd's Biorestorative Therapies shares are currently valued at $15.91M.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.